Results 241 to 250 of about 712,979 (385)

The subcellular distribution of phosphorylated Y‐box‐binding protein‐1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological features

open access: yesMolecular Oncology, EarlyView.
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau   +9 more
wiley   +1 more source

Integrative microbiome- and metatranscriptome-based analyses reveal diagnostic biomarkers for peri-implantitis. [PDF]

open access: yesNPJ Biofilms Microbiomes
Joshi AA   +10 more
europepmc   +1 more source

A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner

open access: yesMolecular Oncology, EarlyView.
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp   +13 more
wiley   +1 more source

Patients in hospital with confirmed bacterial airway infection are significantly more likely to have a respiratory virus co-infection. [PDF]

open access: yesJ Med Microbiol
Hamza YP   +15 more
europepmc   +1 more source

Comparison of five genotypic techniques for identification of optochin-resistant pneumococcus-like isolates [PDF]

open access: yes, 2003
Claeys, Geert   +7 more
core  

Rapid determination of 16S ribosomal RNA sequences for phylogenetic analyses.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1985
D. Lane   +5 more
semanticscholar   +1 more source

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

open access: yesMolecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald   +18 more
wiley   +1 more source

Rapid, Amplification-free, RNA-based Uropathogen Detection With LbuCas13a. [PDF]

open access: yesOpen Forum Infect Dis
Ata H   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy